JP2004503471A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004503471A5 JP2004503471A5 JP2001585800A JP2001585800A JP2004503471A5 JP 2004503471 A5 JP2004503471 A5 JP 2004503471A5 JP 2001585800 A JP2001585800 A JP 2001585800A JP 2001585800 A JP2001585800 A JP 2001585800A JP 2004503471 A5 JP2004503471 A5 JP 2004503471A5
- Authority
- JP
- Japan
- Prior art keywords
- selectin
- pharmaceutical composition
- stroke
- animals
- medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20669300P | 2000-05-24 | 2000-05-24 | |
| US60/206,693 | 2000-05-24 | ||
| PCT/US2001/016583 WO2001089557A2 (en) | 2000-05-24 | 2001-05-23 | Methods for preventing strokes by inducing tolerance to e-selectin |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004503471A JP2004503471A (ja) | 2004-02-05 |
| JP2004503471A5 true JP2004503471A5 (enExample) | 2008-06-26 |
| JP4986361B2 JP4986361B2 (ja) | 2012-07-25 |
Family
ID=22767527
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001585800A Expired - Fee Related JP4986361B2 (ja) | 2000-05-24 | 2001-05-23 | Ｅ−セレクチンに対する寛容誘導による脳卒中防止法 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US7261896B2 (enExample) |
| EP (2) | EP1286686B1 (enExample) |
| JP (1) | JP4986361B2 (enExample) |
| AT (1) | ATE367823T1 (enExample) |
| AU (2) | AU6481301A (enExample) |
| CA (1) | CA2410563C (enExample) |
| DE (1) | DE60129552T2 (enExample) |
| DK (1) | DK1286686T3 (enExample) |
| ES (1) | ES2292594T3 (enExample) |
| PT (1) | PT1286686E (enExample) |
| WO (1) | WO2001089557A2 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1286686B1 (en) * | 2000-05-24 | 2007-07-25 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY of the DEPARTMENT OF HEALTH AND HUMAN SERVICES | E-selectin for treating or preventing stroke |
| WO2007028133A2 (en) * | 2005-08-30 | 2007-03-08 | Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Treatment and prevention of vascular dementia |
| US7897575B2 (en) | 2000-05-24 | 2011-03-01 | The United States Of America As Represented By The Department Of Health And Human Services | Treatment and prevention of vascular dementia |
| US20070244043A1 (en) * | 2005-03-10 | 2007-10-18 | Novavax, Inc. | Recombinant E-selectin made in insect cells |
| US7939078B2 (en) * | 2005-07-07 | 2011-05-10 | Codman & Shurtleff | Methods of enhancing the immune response to autoantigens in mucosal associated lymphatic tissue |
| CA2683127A1 (en) * | 2006-10-09 | 2008-04-17 | Government Of The United States Of America As Represented By The Secreta Ry Of The Department Of Health And Human Services National Institutes Of | Treatment of inflammation, demyelination and neuronal/axonal loss |
| WO2009038880A1 (en) * | 2007-08-01 | 2009-03-26 | Novavax, Inc. | Novel e-selectin variant |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3561444A (en) | 1968-05-22 | 1971-02-09 | Bio Logics Inc | Ultrasonic drug nebulizer |
| US3703173A (en) | 1970-12-31 | 1972-11-21 | Ted A Dixon | Nebulizer and tent assembly |
| US4309406A (en) | 1979-07-10 | 1982-01-05 | American Home Products Corporation | Sustained release pharmaceutical compositions |
| US4309404A (en) | 1979-08-09 | 1982-01-05 | American Home Products Corporation | Sustained release pharmaceutical compositions |
| US4704295A (en) | 1983-09-19 | 1987-11-03 | Colorcon, Inc. | Enteric film-coating compositions |
| US4556552A (en) | 1983-09-19 | 1985-12-03 | Colorcon, Inc. | Enteric film-coating compositions |
| US4624251A (en) | 1984-09-13 | 1986-11-25 | Riker Laboratories, Inc. | Apparatus for administering a nebulized substance |
| US4635627A (en) | 1984-09-13 | 1987-01-13 | Riker Laboratories, Inc. | Apparatus and method |
| US5399347A (en) | 1987-06-24 | 1995-03-21 | Autoimmune, Inc. | Method of treating rheumatoid arthritis with type II collagen |
| US5081034A (en) * | 1988-11-14 | 1992-01-14 | Brigham & Women's Hospital | Cloned genes which encode elam-1 |
| AU670024B2 (en) | 1989-07-14 | 1996-07-04 | Autoimmune, Inc. | Methods of treating or preventing autoimmune uveoretinitis in mammals |
| EP0506785B1 (en) | 1989-12-20 | 2000-03-15 | Autoimmune, Inc. | Improved treatment of autoimmune diseases by aerosol administration of auto antigens |
| EP0782859A1 (en) | 1990-03-02 | 1997-07-09 | Autoimmune, Inc. | Enhancement of the down-regulation of autoimmune diseases by oral administration of autoantigens |
| IL97709A (en) | 1990-03-30 | 2005-05-17 | Brigham & Womens Hospital | Use of an mbp peptide for the preparation of a medicament for the treatment of multiple sclerosis |
| IL99699A (en) | 1990-10-10 | 2002-04-21 | Autoimmune Inc | Drug with the option of oral, intra-intestinal, or inhaled dosing for suppression of autoimmune response associated with type I diabetes |
| IL99754A (en) | 1990-10-15 | 1996-08-04 | Autoimmune Inc | Pharmaceutical preparation containing autoantib or particle or analogue for the treatment of autoimmune arthritis and multiple sclerosis |
| US5593698A (en) | 1990-10-31 | 1997-01-14 | Autoimmune, Inc. | Suppression of proliferative response and induction of tolerance with polymorphic class II MHC allopeptides |
| IL99864A (en) | 1990-10-31 | 2000-11-21 | Autoimmune Inc | Compositions for suppressing transplant rejection in mammals which contain tissue donor derived MHC antigens |
| EP0627933B1 (en) | 1992-02-28 | 2002-11-27 | Autoimmune, Inc. | Bystander suppression of autoimmune diseases |
| BR9306272A (pt) | 1992-04-09 | 1998-06-23 | Autoimmune Inc | Peptídeo e composiçao farmacêutica |
| IL106720A (en) | 1992-08-17 | 1998-10-30 | Autoimmune Inc | The use of antigen bystander in the preparation of compositions for the treatment of neurologically related diseases in mammals and such compositions |
| IL113303A0 (en) | 1994-04-08 | 1995-07-31 | Brigham & Womens Hospital | Treatment of autoimmune disease using oral tolerization and/or type I interferon |
| CA2187345A1 (en) | 1994-04-08 | 1995-10-19 | Howard L. Weiner | Treatment of autoimmune disease using oral tolerization and/or th2-enhancing cytokines |
| US5891645A (en) * | 1994-06-01 | 1999-04-06 | Alexion Pharmaceuticals, Inc. | Porcine E-selectin |
| GB9507768D0 (en) * | 1995-04-13 | 1995-05-31 | Glaxo Group Ltd | Method of apparatus |
| US5948407A (en) * | 1997-03-19 | 1999-09-07 | Shire Laboratories Inc. | Oral induction of tolerance to parenterally administered non-autologous polypeptides |
| US5935577A (en) | 1998-01-23 | 1999-08-10 | Autoimmune Inc. | Treatment of autoimmune disease using tolerization in combination with methotrexate |
| US20010056073A1 (en) * | 1998-07-21 | 2001-12-27 | Ascher Shmulewitz | Gene therapy method for revascularizing ischemic tissue |
| US6974573B2 (en) * | 1999-11-01 | 2005-12-13 | Mucovax Holdings, B.V. | Antibody production in farm animals |
| EP1286686B1 (en) * | 2000-05-24 | 2007-07-25 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY of the DEPARTMENT OF HEALTH AND HUMAN SERVICES | E-selectin for treating or preventing stroke |
| US7897575B2 (en) * | 2000-05-24 | 2011-03-01 | The United States Of America As Represented By The Department Of Health And Human Services | Treatment and prevention of vascular dementia |
-
2001
- 2001-05-23 EP EP01939279A patent/EP1286686B1/en not_active Expired - Lifetime
- 2001-05-23 JP JP2001585800A patent/JP4986361B2/ja not_active Expired - Fee Related
- 2001-05-23 DE DE60129552T patent/DE60129552T2/de not_active Expired - Lifetime
- 2001-05-23 DK DK01939279T patent/DK1286686T3/da active
- 2001-05-23 CA CA2410563A patent/CA2410563C/en not_active Expired - Fee Related
- 2001-05-23 WO PCT/US2001/016583 patent/WO2001089557A2/en not_active Ceased
- 2001-05-23 PT PT01939279T patent/PT1286686E/pt unknown
- 2001-05-23 AU AU6481301A patent/AU6481301A/xx active Pending
- 2001-05-23 AT AT01939279T patent/ATE367823T1/de active
- 2001-05-23 EP EP10183986A patent/EP2295067A1/en not_active Withdrawn
- 2001-05-23 US US10/296,423 patent/US7261896B2/en not_active Expired - Fee Related
- 2001-05-23 AU AU2001264813A patent/AU2001264813B2/en not_active Ceased
- 2001-05-23 ES ES01939279T patent/ES2292594T3/es not_active Expired - Lifetime
-
2007
- 2007-06-19 US US11/820,326 patent/US20070253975A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0206432A2 (pt) | métodos para administrar dois ou mais agentes terapêuticos ativos e para tratar diabetes melito ou sintomas associados com diabetes melito em um humano e sistema de liberação espaçada de medicamento | |
| EA200300046A1 (ru) | Быстро увеличивающаяся в объеме композиция для удерживания и контролированного выделения терапевтических агентов в желудке и лекарственные формы, включающие композицию | |
| ATE355065T1 (de) | Therapeutische zusammensetzungen bestehend aus antihypotensiva und antiangiogenika | |
| IL195723A (en) | Use of p53 inhibitors for the preparation of medicament | |
| JP2006501240A5 (enExample) | ||
| AR020050A1 (es) | COMPOSICION FARMACEUTICA PARA EL TRATAMIENTO DE LA ENFERMEDAD AMILOIDOGENICA USO DE UN PÉPTIDO ABETA PARA LA PREPARACIoN DE MEDICAMENTOS | |
| SE9703191D0 (sv) | Medicament for improvement of duration of muscle function or treatment of muscle disorders or diseases | |
| JP2002532432A5 (enExample) | ||
| CA2503810A1 (en) | Therapeutic agent for fibromyalgia | |
| ATE251901T1 (de) | Transdermales therapeutisches system für die erzielung hoher plasmaspiegel von rotigotin in der therapie von morbus parkinson | |
| BRPI0414347A (pt) | associação compreendendo um ligando de alfa-2-delta e um ssri e/ou snri para tratamento de depressão e distúrbios da ansiedade | |
| RU2004135563A (ru) | Лекарственное средство для лечения повышенной активности мочевого пузыря | |
| EA200600817A1 (ru) | Антагонисты в1 рецептора брадикинина (варианты), фармацевтическая композиция, лекарственное средство, способ лечения заболеваний (варианты) | |
| IL161889A (en) | Use of omega interferon in the manufacture of a medicament for treating viral disease | |
| JP2004537500A5 (enExample) | ||
| UA83320C2 (ru) | Таблетка для рассасывания, содержащая октенидин и предназначенная для лечения воспалительных заболеваний полости рта и глотки | |
| JP2004503471A5 (enExample) | ||
| RU2002122084A (ru) | Комбинация лекарственных препаратов, включающая миртазапин, для лечения депрессии и связанных растройств | |
| EP1262197A3 (en) | Combination treatment for sleep disorders including sleep apnea | |
| DK1343472T3 (da) | Thixotropisk næsespray | |
| JP2003528919A5 (enExample) | ||
| Club et al. | Autism Spectrum Disorders | |
| JP2002540148A5 (enExample) | ||
| RU2005135649A (ru) | Комбинации пароксетина и 4-(s)-(4-ацетилпиперазин-1-ил)-2-(r)-(4-фтор-2-метилфенил)пиперидин-1-карбоновой кислоты [1-(r)-(3, 5-бис-трифторметилфенил)этил]метиламида для лечения депрессии и/или тревоги | |
| BR0104586A (pt) | Método para tratamento de neurodegeneração |